320 related articles for article (PubMed ID: 7741839)
1. Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
Choy AM; Darbar D; Lang CC; Pringle TH; McNeill GP; Kennedy NS; Struthers AD
Br Heart J; 1994 Jul; 72(1):16-22. PubMed ID: 7741839
[TBL] [Abstract][Full Text] [Related]
2. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
[TBL] [Abstract][Full Text] [Related]
3. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.
Omland T; Aakvaag A; Bonarjee VV; Caidahl K; Lie RT; Nilsen DW; Sundsfjord JA; Dickstein K
Circulation; 1996 Jun; 93(11):1963-9. PubMed ID: 8640969
[TBL] [Abstract][Full Text] [Related]
4. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function.
Bonarjee VV; Omland T; Nilsen DW; Caidahl K; Sundsfjord JA; Dickstein K
Br Heart J; 1995 Jun; 73(6):511-6. PubMed ID: 7626348
[TBL] [Abstract][Full Text] [Related]
5. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
6. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction.
Motwani JG; McAlpine H; Kennedy N; Struthers AD
Lancet; 1993 May; 341(8853):1109-13. PubMed ID: 8097802
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group.
Richards AM; Nicholls MG; Yandle TG; Ikram H; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Frampton C; Crozier IG; Smyth DW
Heart; 1999 Feb; 81(2):114-20. PubMed ID: 9922344
[TBL] [Abstract][Full Text] [Related]
8. Augmented secretion of atrial and brain natriuretic peptides during dynamic exercise in patients with old myocardial infarction.
Marumoto K; Hamada M; Aburaya M; Hiwada K
Jpn Circ J; 1995 Nov; 59(11):715-24. PubMed ID: 8747761
[TBL] [Abstract][Full Text] [Related]
9. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.
Yamamoto K; Burnett JC; Jougasaki M; Nishimura RA; Bailey KR; Saito Y; Nakao K; Redfield MM
Hypertension; 1996 Dec; 28(6):988-94. PubMed ID: 8952587
[TBL] [Abstract][Full Text] [Related]
10. Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction.
Squire IB; Evans J; Ng LL; Loftus IM; Thompson MM
J Card Fail; 2004 Aug; 10(4):328-33. PubMed ID: 15309700
[TBL] [Abstract][Full Text] [Related]
11. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction.
Nagaya N; Nishikimi T; Goto Y; Miyao Y; Kobayashi Y; Morii I; Daikoku S; Matsumoto T; Miyazaki S; Matsuoka H; Takishita S; Kangawa K; Matsuo H; Nonogi H
Am Heart J; 1998 Jan; 135(1):21-8. PubMed ID: 9453517
[TBL] [Abstract][Full Text] [Related]
12. Occurrence and predictors of left ventricular systolic dysfunction at hospital discharge and in long-term follow-up after acute myocardial infarction treated with primary percutaneous coronary intervention.
Świątkiewicz I; Magielski P; Woźnicki M; Gierach J; Jabłoński M; Fabiszak T; Koziński M; Sukiennik A; Bronisz A; Kubica J
Kardiol Pol; 2012; 70(4):329-40. PubMed ID: 22528703
[TBL] [Abstract][Full Text] [Related]
13. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of plasma atrial and brain natriuretic peptide levels during hemodialysis in hemodialysis patients with old myocardial infarction].
Uetake S; Takahashi M; Tamano K; Honda T; Kobayashi T; Horinaka S
J Cardiol; 2001 Aug; 38(2):61-71. PubMed ID: 11525111
[TBL] [Abstract][Full Text] [Related]
15. Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment.
Omland T; Aakvaag A; Vik-Mo H
Heart; 1996 Sep; 76(3):232-7. PubMed ID: 8868981
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide is a sensitive indicator of impaired left-ventricular function in elderly patients with cardiovascular disease.
Yamada Y; Goto J; Yokota M
Cardiology; 1997; 88(5):401-7. PubMed ID: 9286500
[TBL] [Abstract][Full Text] [Related]
17. Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography.
Ceriani L; Giovanella L
Clin Chem Lab Med; 2007; 45(2):226-31. PubMed ID: 17311513
[TBL] [Abstract][Full Text] [Related]
18. Natriuretic peptides and cyclic guanosine 3',5'-monophosphate in asymptomatic and symptomatic left ventricular dysfunction.
Friedl W; Mair J; Thomas S; Pichler M; Puschendorf B
Heart; 1996 Aug; 76(2):129-36. PubMed ID: 8795474
[TBL] [Abstract][Full Text] [Related]
19. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
20. Comparison of atrial natriuretic peptide B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction.
Davidson NC; Naas AA; Hanson JK; Kennedy NS; Coutie WJ; Struthers AD
Am J Cardiol; 1996 Apr; 77(10):828-31. PubMed ID: 8623734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
